In Vitro Evaluation of Bioequiavailability of Felodipine Sustained-Release Tablets from Different Manufactures by Fiber-Optic Dissolution Test
LIU Yang,LI Xinxia,ZHENG Limin,LI Li,GENG Dongsheng
DOI: https://doi.org/10.3969/j.issn.1004-2407.2012.02.023
2012-01-01
Abstract:Objective To monitor the release rate of Felodipine Sustained-Release Tablets with fiber-optic dissolution test(FODT),and to employ f2 factor to compare the similarity of Felodipine Sustained-Release Tablets dissolution curve.Methods Apparatus 2 with the paddle rotation of 200 r·min-1,4 g·L-1 hexadecyltrimethylammonium bromide phosphate buffer(pH6.5) 500 mL as dissolution medium was used.With a probe of 5 mm path,the detect wavelength was 365 nm and the reference wavelength was 420 nm.Results The accumulated release of Felodipine Extended-Release Tablets A at 1,4 and 7 h were 9.10%,52.1% and 78.7%,respectively;RSD were 15.9%,7.36%,and 5.58%,respectively;Factory B were 14.0%,63.4%,and 96.5%,respectively;RSD were 32.1%,23.6% and 14.2%,respectively;Factory C were 12.1%,49.4%,and 80.5%,respectively;RSD were 35.3%,28.0% and 22.4%,respectively.Conclusion Felodipine Sustained-Release Tablets from three manufacturers are all disqualification.The consistency of dissolution profile of B and C is poor,it does not meet the conditions of the f2 factor evaluation.